EMEA (Europe, Middle East and Africa) Pneumococcal Vaccines Market Report 2017

November 2017 | 128 pages | ID: EB0A60F470AEN
QYResearch

Abstracts

In this report, the EMEA Pneumococcal Vaccines market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Pneumococcal Vaccines for these regions, from 2012 to 2022 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Pneumococcal Vaccines market competition by top manufacturers/players, with Pneumococcal Vaccines sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including

• Pfizer
• Sanofi
• GSK
• Merck
• Eli Lilly
• AstraZeneca
• Abera
• S K Chemicals
• Beijing Minhai Biotechnology
• Baxter
• Biken
• Celgene Corporation
• Panacea Biotec
• Serum Institute of India
• Genentech
• Genocea Biosciences
• ImmunoBiology
• Lupin
• Nuron Biotech
• Biogen
• Valneva Austria
• Sinovac

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

• PPSV 23
• PCV 7/13
• PCV 10

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• For Infants
• For Children (2-10)
• For Person (10-64)
• For The Old (?65)

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) Pneumococcal Vaccines Market Report 2017

1 PNEUMOCOCCAL VACCINES OVERVIEW

1.1 Product Overview and Scope of Pneumococcal Vaccines
1.2 Classification of Pneumococcal Vaccines
  1.2.1 EMEA Pneumococcal Vaccines Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA Pneumococcal Vaccines Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 PPSV
  1.2.4 PCV 7/13
  1.2.5 PCV
1.3 EMEA Pneumococcal Vaccines Market by Application/End Users
  1.3.1 EMEA Pneumococcal Vaccines Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.2 For Infants
  1.3.3 For Children (2-10)
  1.3.4 For Person (10-64)
  1.3.5 For The Old (?65)
1.4 EMEA Pneumococcal Vaccines Market by Region
  1.4.1 EMEA Pneumococcal Vaccines Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Pneumococcal Vaccines (2012-2022)
  1.5.1 EMEA Pneumococcal Vaccines Sales and Growth Rate (2012-2022)
  1.5.2 EMEA Pneumococcal Vaccines Revenue and Growth Rate (2012-2022)

2 EMEA PNEUMOCOCCAL VACCINES COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Pneumococcal Vaccines Market Competition by Players/Manufacturers
  2.1.1 EMEA Pneumococcal Vaccines Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA Pneumococcal Vaccines Revenue and Share by Players (2012-2017)
  2.1.3 EMEA Pneumococcal Vaccines Sale Price by Players (2012-2017)
2.2 EMEA Pneumococcal Vaccines (Volume and Value) by Type/Product Category
  2.2.1 EMEA Pneumococcal Vaccines Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA Pneumococcal Vaccines Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA Pneumococcal Vaccines Sale Price by Type (2012-2017)
2.3 EMEA Pneumococcal Vaccines (Volume) by Application
2.4 EMEA Pneumococcal Vaccines (Volume and Value) by Region
  2.4.1 EMEA Pneumococcal Vaccines Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA Pneumococcal Vaccines Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA Pneumococcal Vaccines Sales Price by Region (2012-2017)

3 EUROPE PNEUMOCOCCAL VACCINES (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Pneumococcal Vaccines Sales and Value (2012-2017)
  3.1.1 Europe Pneumococcal Vaccines Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe Pneumococcal Vaccines Revenue and Growth Rate (2012-2017)
3.2 Europe Pneumococcal Vaccines Sales and Market Share by Type
3.3 Europe Pneumococcal Vaccines Sales and Market Share by Application
3.4 Europe Pneumococcal Vaccines Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Pneumococcal Vaccines Sales Volume by Countries (2012-2017)
  3.4.2 Europe Pneumococcal Vaccines Revenue by Countries (2012-2017)
  3.4.3 Germany Pneumococcal Vaccines Sales and Growth Rate (2012-2017)
  3.4.4 France Pneumococcal Vaccines Sales and Growth Rate (2012-2017)
  3.4.5 UK Pneumococcal Vaccines Sales and Growth Rate (2012-2017)
  3.4.6 Russia Pneumococcal Vaccines Sales and Growth Rate (2012-2017)
  3.4.7 Italy Pneumococcal Vaccines Sales and Growth Rate (2012-2017)
  3.4.8 Benelux Pneumococcal Vaccines Sales and Growth Rate (2012-2017)

4 MIDDLE EAST PNEUMOCOCCAL VACCINES (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Pneumococcal Vaccines Sales and Value (2012-2017)
  4.1.1 Middle East Pneumococcal Vaccines Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East Pneumococcal Vaccines Revenue and Growth Rate (2012-2017)
4.2 Middle East Pneumococcal Vaccines Sales and Market Share by Type
4.3 Middle East Pneumococcal Vaccines Sales and Market Share by Application
4.4 Middle East Pneumococcal Vaccines Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Pneumococcal Vaccines Sales Volume by Countries (2012-2017)
  4.4.2 Middle East Pneumococcal Vaccines Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia Pneumococcal Vaccines Sales and Growth Rate (2012-2017)
  4.4.4 Israel Pneumococcal Vaccines Sales and Growth Rate (2012-2017)
  4.4.5 UAE Pneumococcal Vaccines Sales and Growth Rate (2012-2017)
  4.4.6 Iran Pneumococcal Vaccines Sales and Growth Rate (2012-2017)

5 AFRICA PNEUMOCOCCAL VACCINES (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Pneumococcal Vaccines Sales and Value (2012-2017)
  5.1.1 Africa Pneumococcal Vaccines Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa Pneumococcal Vaccines Revenue and Growth Rate (2012-2017)
5.2 Africa Pneumococcal Vaccines Sales and Market Share by Type
5.3 Africa Pneumococcal Vaccines Sales and Market Share by Application
5.4 Africa Pneumococcal Vaccines Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Pneumococcal Vaccines Sales Volume by Countries (2012-2017)
  5.4.2 Africa Pneumococcal Vaccines Revenue by Countries (2012-2017)
  5.4.3 South Africa Pneumococcal Vaccines Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria Pneumococcal Vaccines Sales and Growth Rate (2012-2017)
  5.4.5 Egypt Pneumococcal Vaccines Sales and Growth Rate (2012-2017)
  5.4.6 Algeria Pneumococcal Vaccines Sales and Growth Rate (2012-2017)

6 EMEA PNEUMOCOCCAL VACCINES MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 Pfizer
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Pneumococcal Vaccines Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Pfizer Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Sanofi
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Pneumococcal Vaccines Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Sanofi Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 GSK
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Pneumococcal Vaccines Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 GSK Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Merck
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Pneumococcal Vaccines Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Merck Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Eli Lilly
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Pneumococcal Vaccines Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Eli Lilly Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 AstraZeneca
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Pneumococcal Vaccines Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 AstraZeneca Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Abera
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Pneumococcal Vaccines Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Abera Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 S K Chemicals
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Pneumococcal Vaccines Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 S K Chemicals Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Beijing Minhai Biotechnology
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Pneumococcal Vaccines Product Type, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Beijing Minhai Biotechnology Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Baxter
  6.10.1 Company Basic Information, Manufacturing Base and Competitors
  6.10.2 Pneumococcal Vaccines Product Type, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Baxter Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Biken
6.12 Celgene Corporation
6.13 Panacea Biotec
6.14 Serum Institute of India
6.15 Genentech
6.16 Genocea Biosciences
6.17 ImmunoBiology
6.18 Lupin
6.19 Nuron Biotech
6.20 Biogen
6.21 Valneva Austria
6.22 Sinovac

7 PNEUMOCOCCAL VACCINES MANUFACTURING COST ANALYSIS

7.1 Pneumococcal Vaccines Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Pneumococcal Vaccines

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Pneumococcal Vaccines Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Pneumococcal Vaccines Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA PNEUMOCOCCAL VACCINES MARKET FORECAST (2017-2022)

11.1 EMEA Pneumococcal Vaccines Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA Pneumococcal Vaccines Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA Pneumococcal Vaccines Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA Pneumococcal Vaccines Price and Trend Forecast (2017-2022)
11.2 EMEA Pneumococcal Vaccines Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Pneumococcal Vaccines Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Pneumococcal Vaccines Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Pneumococcal Vaccines Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Pneumococcal Vaccines Sales Forecast by Type (2017-2022)
11.7 EMEA Pneumococcal Vaccines Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Pneumococcal Vaccines
Figure EMEA Pneumococcal Vaccines Sales Volume (K Units) by Type (2012-2022)
Figure EMEA Pneumococcal Vaccines Sales Volume Market Share by Type (Product Category) in 2016
Figure PPSV 23 Product Picture
Figure PCV 7/13 Product Picture
Figure PCV 10 Product Picture
Figure EMEA Pneumococcal Vaccines Sales Volume (K Units) by Application (2012-2022)
Figure EMEA Sales Market Share of Pneumococcal Vaccines by Application in 2016
Figure For Infants Examples
Table Key Downstream Customer in For Infants
Figure For Children (2-10) Examples
Table Key Downstream Customer in For Children (2-10)
Figure For Person (10-64) Examples
Table Key Downstream Customer in For Person (10-64)
Figure For The Old (?65) Examples
Table Key Downstream Customer in For The Old (?65)
Figure EMEA Pneumococcal Vaccines Market Size (Million USD) by Region (2012-2022)
Figure Europe Pneumococcal Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Pneumococcal Vaccines Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Pneumococcal Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Pneumococcal Vaccines Revenue (Million USD) Status and Forecast by Countries
Figure Africa Pneumococcal Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Pneumococcal Vaccines Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Pneumococcal Vaccines Sales Volume and Growth Rate (2012-2022)
Figure EMEA Pneumococcal Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Pneumococcal Vaccines Market Major Players Product Sales Volume (K Units) (2012-2017)
Table EMEA Pneumococcal Vaccines Sales Volume (K Units) of Major Players (2012-2017)
Table EMEA Pneumococcal Vaccines Sales Share by Players (2012-2017)
Figure 2016 Pneumococcal Vaccines Sales Share by Players
Figure 2017 Pneumococcal Vaccines Sales Share by Players
Figure EMEA Pneumococcal Vaccines Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Pneumococcal Vaccines Revenue (Million USD) by Players (2012-2017)
Table EMEA Pneumococcal Vaccines Revenue Share by Players (2012-2017)
Table 2016 EMEA Pneumococcal Vaccines Revenue Share by Players
Table 2017 EMEA Pneumococcal Vaccines Revenue Share by Players
Table EMEA Pneumococcal Vaccines Sale Price (USD/Unit) by Players (2012-2017)
Table EMEA Pneumococcal Vaccines Sales (K Units) and Market Share by Type (2012-2017)
Table EMEA Pneumococcal Vaccines Sales Share by Type (2012-2017)
Figure Sales Market Share of Pneumococcal Vaccines by Type (2012-2017)
Figure EMEA Pneumococcal Vaccines Sales Market Share by Type (2012-2017)
Table EMEA Pneumococcal Vaccines Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Pneumococcal Vaccines Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Pneumococcal Vaccines by Type in 2016
Table EMEA Pneumococcal Vaccines Sale Price (USD/Unit) by Type (2012-2017)
Table EMEA Pneumococcal Vaccines Sales (K Units) and Market Share by Application (2012-2017)
Table EMEA Pneumococcal Vaccines Sales Share by Application (2012-2017)
Figure Sales Market Share of Pneumococcal Vaccines by Application (2012-2017)
Figure EMEA Pneumococcal Vaccines Sales Market Share by Application in 2016
Table EMEA Pneumococcal Vaccines Sales (K Units) and Market Share by Region (2012-2017)
Table EMEA Pneumococcal Vaccines Sales Share by Region (2012-2017)
Figure Sales Market Share of Pneumococcal Vaccines by Region (2012-2017)
Figure EMEA Pneumococcal Vaccines Sales Market Share in 2016
Table EMEA Pneumococcal Vaccines Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Pneumococcal Vaccines Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Pneumococcal Vaccines by Region (2012-2017)
Figure EMEA Pneumococcal Vaccines Revenue Market Share Regions in 2016
Table EMEA Pneumococcal Vaccines Sales Price (USD/Unit) by Region (2012-2017)
Figure Europe Pneumococcal Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure Europe Pneumococcal Vaccines Revenue and Growth Rate (2012-2017)
Table Europe Pneumococcal Vaccines Sales (K Units) by Type (2012-2017)
Table Europe Pneumococcal Vaccines Market Share by Type (2012-2017)
Figure Europe Pneumococcal Vaccines Market Share by Type in 2016
Table Europe Pneumococcal Vaccines Sales (K Units) by Application (2012-2017)
Table Europe Pneumococcal Vaccines Market Share by Application (2012-2017)
Figure Europe Pneumococcal Vaccines Market Share by Application in 2016
Table Europe Pneumococcal Vaccines Sales (K Units) by Countries (2012-2017)
Table Europe Pneumococcal Vaccines Sales Market Share by Countries (2012-2017)
Figure Europe Pneumococcal Vaccines Sales Market Share by Countries (2012-2017)
Figure Europe Pneumococcal Vaccines Sales Market Share by Countries in 2016
Table Europe Pneumococcal Vaccines Revenue (Million USD) by Countries (2012-2017)
Table Europe Pneumococcal Vaccines Revenue Market Share by Countries (2012-2017)
Figure Europe Pneumococcal Vaccines Revenue Market Share by Countries (2012-2017)
Figure Europe Pneumococcal Vaccines Revenue Market Share by Countries in 2016
Figure Germany Pneumococcal Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure France Pneumococcal Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure UK Pneumococcal Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure Russia Pneumococcal Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure Italy Pneumococcal Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure Benelux Pneumococcal Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East Pneumococcal Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East Pneumococcal Vaccines Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Pneumococcal Vaccines Sales (K Units) by Type (2012-2017)
Table Middle East Pneumococcal Vaccines Market Share by Type (2012-2017)
Figure Middle East Pneumococcal Vaccines Market Share by Type (2012-2017)
Table Middle East Pneumococcal Vaccines Sales (K Units) by Applications (2012-2017)
Table Middle East Pneumococcal Vaccines Market Share by Applications (2012-2017)
Figure Middle East Pneumococcal Vaccines Sales Market Share by Application in 2016
Table Middle East Pneumococcal Vaccines Sales Volume (K Units) by Countries (2012-2017)
Table Middle East Pneumococcal Vaccines Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Pneumococcal Vaccines Sales Volume Market Share by Countries in 2016
Table Middle East Pneumococcal Vaccines Revenue (Million USD) by Countries (2012-2017)
Table Middle East Pneumococcal Vaccines Revenue Market Share by Countries (2012-2017)
Figure Middle East Pneumococcal Vaccines Revenue Market Share by Countries (2012-2017)
Figure Middle East Pneumococcal Vaccines Revenue Market Share by Countries in 2016
Figure Saudi Arabia Pneumococcal Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure Israel Pneumococcal Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure UAE Pneumococcal Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure Iran Pneumococcal Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure Africa Pneumococcal Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure Africa Pneumococcal Vaccines Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Pneumococcal Vaccines Sales (K Units) by Type (2012-2017)
Table Africa Pneumococcal Vaccines Sales Market Share by Type (2012-2017)
Figure Africa Pneumococcal Vaccines Sales Market Share by Type (2012-2017)
Figure Africa Pneumococcal Vaccines Sales Market Share by Type in 2016
Table Africa Pneumococcal Vaccines Sales (K Units) by Application (2012-2017)
Table Africa Pneumococcal Vaccines Sales Market Share by Application (2012-2017)
Figure Africa Pneumococcal Vaccines Sales Market Share by Application (2012-2017)
Table Africa Pneumococcal Vaccines Sales Volume (K Units) by Countries (2012-2017)
Table Africa Pneumococcal Vaccines Sales Market Share by Countries (2012-2017)
Figure Africa Pneumococcal Vaccines Sales Market Share by Countries (2012-2017)
Figure Africa Pneumococcal Vaccines Sales Market Share by Countries in 2016
Table Africa Pneumococcal Vaccines Revenue (Million USD) by Countries (2012-2017)
Table Africa Pneumococcal Vaccines Revenue Market Share by Countries (2012-2017)
Figure Africa Pneumococcal Vaccines Revenue Market Share by Countries (2012-2017)
Figure Africa Pneumococcal Vaccines Revenue Market Share by Countries in 2016
Figure South Africa Pneumococcal Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure Nigeria Pneumococcal Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure Egypt Pneumococcal Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure Algeria Pneumococcal Vaccines Sales (K Units) and Growth Rate (2012-2017)
Table Pfizer Pneumococcal Vaccines Basic Information List
Table Pfizer Pneumococcal Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Pfizer Pneumococcal Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure Pfizer Pneumococcal Vaccines Sales Market Share in EMEA (2012-2017)
Figure Pfizer Pneumococcal Vaccines Revenue Market Share in EMEA (2012-2017)
Table Sanofi Pneumococcal Vaccines Basic Information List
Table Sanofi Pneumococcal Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Sanofi Pneumococcal Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure Sanofi Pneumococcal Vaccines Sales Market Share in EMEA (2012-2017)
Figure Sanofi Pneumococcal Vaccines Revenue Market Share in EMEA (2012-2017)
Table GSK Pneumococcal Vaccines Basic Information List
Table GSK Pneumococcal Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure GSK Pneumococcal Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure GSK Pneumococcal Vaccines Sales Market Share in EMEA (2012-2017)
Figure GSK Pneumococcal Vaccines Revenue Market Share in EMEA (2012-2017)
Table Merck Pneumococcal Vaccines Basic Information List
Table Merck Pneumococcal Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Merck Pneumococcal Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure Merck Pneumococcal Vaccines Sales Market Share in EMEA (2012-2017)
Figure Merck Pneumococcal Vaccines Revenue Market Share in EMEA (2012-2017)
Table Eli Lilly Pneumococcal Vaccines Basic Information List
Table Eli Lilly Pneumococcal Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Eli Lilly Pneumococcal Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure Eli Lilly Pneumococcal Vaccines Sales Market Share in EMEA (2012-2017)
Figure Eli Lilly Pneumococcal Vaccines Revenue Market Share in EMEA (2012-2017)
Table AstraZeneca Pneumococcal Vaccines Basic Information List
Table AstraZeneca Pneumococcal Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure AstraZeneca Pneumococcal Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure AstraZeneca Pneumococcal Vaccines Sales Market Share in EMEA (2012-2017)
Figure AstraZeneca Pneumococcal Vaccines Revenue Market Share in EMEA (2012-2017)
Table Abera Pneumococcal Vaccines Basic Information List
Table Abera Pneumococcal Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Abera Pneumococcal Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure Abera Pneumococcal Vaccines Sales Market Share in EMEA (2012-2017)
Figure Abera Pneumococcal Vaccines Revenue Market Share in EMEA (2012-2017)
Table S K Chemicals Pneumococcal Vaccines Basic Information List
Table S K Chemicals Pneumococcal Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure S K Chemicals Pneumococcal Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure S K Chemicals Pneumococcal Vaccines Sales Market Share in EMEA (2012-2017)
Figure S K Chemicals Pneumococcal Vaccines Revenue Market Share in EMEA (2012-2017)
Table Beijing Minhai Biotechnology Pneumococcal Vaccines Basic Information List
Table Beijing Minhai Biotechnology Pneumococcal Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Beijing Minhai Biotechnology Pneumococcal Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure Beijing Minhai Biotechnology Pneumococcal Vaccines Sales Market Share in EMEA (2012-2017)
Figure Beijing Minhai Biotechnology Pneumococcal Vaccines Revenue Market Share in EMEA (2012-2017)
Table Baxter Pneumococcal Vaccines Basic Information List
Table Baxter Pneumococcal Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Baxter Pneumococcal Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure Baxter Pneumococcal Vaccines Sales Market Share in EMEA (2012-2017)
Figure Baxter Pneumococcal Vaccines Revenue Market Share in EMEA (2012-2017)
Table Biken Pneumococcal Vaccines Basic Information List
Table Celgene Corporation Pneumococcal Vaccines Basic Information List
Table Panacea Biotec Pneumococcal Vaccines Basic Information List
Table Serum Institute of India Pneumococcal Vaccines Basic Information List
Table Genentech Pneumococcal Vaccines Basic Information List
Table Genocea Biosciences Pneumococcal Vaccines Basic Information List
Table ImmunoBiology Pneumococcal Vaccines Basic Information List
Table Lupin Pneumococcal Vaccines Basic Information List
Table Nuron Biotech Pneumococcal Vaccines Basic Information List
Table Biogen Pneumococcal Vaccines Basic Information List
Table Valneva Austria Pneumococcal Vaccines Basic Information List
Table Sinovac Pneumococcal Vaccines Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Pneumococcal Vaccines
Figure Manufacturing Process Analysis of Pneumococcal Vaccines
Figure Pneumococcal Vaccines Industrial Chain Analysis
Table Raw Materials Sources of Pneumococcal Vaccines Major Manufacturers in 2016
Table Major Buyers of Pneumococcal Vaccines
Table Distributors/Traders List
Figure EMEA Pneumococcal Vaccines Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure EMEA Pneumococcal Vaccines Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Pneumococcal Vaccines Price (USD/Unit) and Trend Forecast (2017-2022)
Table EMEA Pneumococcal Vaccines Sales (K Units) Forecast by Region (2017-2022)
Figure EMEA Pneumococcal Vaccines Sales Market Share Forecast by Region (2017-2022)
Table EMEA Pneumococcal Vaccines Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Pneumococcal Vaccines Revenue Market Share Forecast by Region (2017-2022)
Table Europe Pneumococcal Vaccines Sales (K Units) Forecast by Countries (2017-2022)
Figure Europe Pneumococcal Vaccines Sales Market Share Forecast by Countries (2017-2022)
Table Europe Pneumococcal Vaccines Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Pneumococcal Vaccines Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Pneumococcal Vaccines Sales (K Units) Forecast by Countries (2017-2022)
Figure Middle East Pneumococcal Vaccines Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Pneumococcal Vaccines Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Pneumococcal Vaccines Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Pneumococcal Vaccines Sales (K Units) Forecast by Countries (2017-2022)
Figure Africa Pneumococcal Vaccines Sales Market Share Forecast by Countries (2017-2022)
Table Africa Pneumococcal Vaccines Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Pneumococcal Vaccines Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Pneumococcal Vaccines Sales (K Units) Forecast by Type (2017-2022)
Figure EMEA Pneumococcal Vaccines Sales Market Share Forecast by Type (2017-2022)
Table EMEA Pneumococcal Vaccines Sales (K Units) Forecast by Application (2017-2022)
Figure EMEA Pneumococcal Vaccines Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources